ArticleFrontiers in immunology2026

Efficacy and safety of telitacicept as an add-on therapy for relapsing lupus nephritis: a retrospective cohort study.

Cui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.